ArticleBlood advances2022

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study.

Alberto Fresa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.